Rapid peptide turnover and inefficient presentation of exogenous antigen critically limit the activation of self-reactive CTL by dendritic cells

Journal of Immunology

Volumn 166, Issue 6, 2001, Pages 3678-3687

  Ludewig, B ^a   McCoy, K ^a   Pericin, M ^a   Ochsenbein, A F ^a   Dumrese, T ^a   Odermatt, B ^a   Toes, R E M ^a   Melief, C J M ^a   Hengartner, H ^a   Zinkernagel, R M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DIABETES MELLITUS; EFFECTOR CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

EID: 0035869558     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.6.3678     Document Type: Article

References (46)

1. Immunologically privileged sites
2. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice
3. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response
4. Levels of peripheral T cell tolerance induced by different doses of tolerogen
5. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction
6. Dendritic cells and the control of immunity
7. Capture and processing of exogenous antigens for presentation on MHC molecules
8. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells
9. Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens
10. + cytotoxic T lymphocytes
11. Dendritic cells acquire antigen from apoptotic cells and induce class I- restricted CTLs
12. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay
13. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity
14. + T cell tolerance to peripherally expressed antigens
15. + T cell help
16. + T cells to cause immunopathotogy
17. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides
18. Virus-specific MHC-ctass II-restricted TCR-transgenic mice: Effects on humoral and cellular immune responses after viral infection
19. Fibroblasts as efficient antigen-presenting cells in lymphoid organs
20. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
21. The SCID but not the RAG-2 gene product is required for Sμ-Sε heavy chain class switching
22. CTLA-4 can function as a negative regulator of T cell activation
23. Characterization of virus-specific cytotoxic T cell clones from allogeneic bone marrow chimeras
24. Dendritic cells efficiently induce protective antiviral immunity
25. + memory T cells in virus-infected hosts
26. Viral immune evasion due to persistence of activated T cells without effector function
27. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue
28. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
29. Cross-presentation: A general mechanism for CTL immunity and tolerance
30. Immune surveillance against a solid tumor fails because of immunological ignorance
31. Maturation, activation, and protection of dendritic cells induced by doublestranded RNA
32. Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response
33. + T-helper and a T-killer cell
34. + T cells mediate CD40-independent maturation of dendritic cells in vivo
35. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement
36. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system
37. Constitutive class I-restricted exogenous presentation of self antigens in vivo
38. Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels
39. + T cells
40. On the various manifestations of spontaneous autoimmune diabetes in rodent models
41. + T cell-mediated spontaneous diabetes in neonatal mice
42. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - A feasibility study
43. Follow-up evaluation of a phase II prostate cancer vaccine trial
44. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
45. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
46. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules